Product Liability Litigation Impeding R&D, FDA Commissioner Says

Pharmaceutical research and development is suffering because of the high cost of product liability litigation, FDA Commissioner McClellan said at a U.S. Chamber of Commerce conference in Washington, D.C. July 15